Correlation Between Kura Oncology and AnaptysBio
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and AnaptysBio, you can compare the effects of market volatilities on Kura Oncology and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and AnaptysBio.
Diversification Opportunities for Kura Oncology and AnaptysBio
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kura and AnaptysBio is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Kura Oncology i.e., Kura Oncology and AnaptysBio go up and down completely randomly.
Pair Corralation between Kura Oncology and AnaptysBio
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the AnaptysBio. But the stock apears to be less risky and, when comparing its historical volatility, Kura Oncology is 1.02 times less risky than AnaptysBio. The stock trades about -0.15 of its potential returns per unit of risk. The AnaptysBio is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 3,677 in AnaptysBio on August 28, 2024 and sell it today you would lose (1,267) from holding AnaptysBio or give up 34.46% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Kura Oncology vs. AnaptysBio
Performance |
Timeline |
Kura Oncology |
AnaptysBio |
Kura Oncology and AnaptysBio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kura Oncology and AnaptysBio
The main advantage of trading using opposite Kura Oncology and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |